News | Business
28 Mar 2017 3:30
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • News
  • Sport
  • Weather
  • Olympic Games
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Business

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.

    21 March 2017

    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Business News
     27 Mar: NZ shares fall on Trump healthcare failure
     27 Mar: Record Adele crowds use public transport
     27 Mar: Electricity firm extends run of losses
     27 Mar: GeoOp sounds out interest for ASX listing
     27 Mar: Kiwi steady after Trump's Obamacare defeat
     27 Mar: Houses needed on Wellington fringes: Mayor
     25 Mar: Chinese dairy giant expands NZ plant
     Top Stories

    RUGBY RUGBY
    Smith speaks of airport tryst regrets More...


    BUSINESS BUSINESS
    NZ shares fall on Trump healthcare failure More...



     Today's News

    International:
    London attack: Women gather on Westminster Bridge in silence to remember victims 22:07

    Rugby League:
    Friend all smiles for NRL Roosters again 21:57

    Entertainment:
    Caroline Flack is plotting her own music career 21:42

    Law and Order:
    Ute a police focus in Dunedin sex assaults 21:17

    Entertainment:
    Kendall Jenner "fully flipped" out when she came face to face with her alleged stalker 21:12

    Christchurch:
    US tramper found near Rakaia River 20:57

    Entertainment:
    Marc Anthony says Jennifer Lopez is his "girl for life" 20:42

    Entertainment:
    James Corden is "very very humbled" by the success of 'The Late Late Show with James Corden' 20:12

    Entertainment:
    Katie Price and Kieran Hayler are returning to the Maldives for the "honeymoon of her dreams" 19:42

    Cricket:
    Williamson bags Test record, NZ ahead 19:17


     News Search






    Power Search


    © 2017 New Zealand City Ltd